Factual end-of-day data for AUROPHARMA: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 6,79,792 shares was close to the 20-day average.
AUROPHARMA's delivery share of 45.4% was below its 20-day average of 51.1%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 20,847 shares on the buy side vs 3,513 on the sell side.
Largest single buy-side trade: 1,235 shares at ₹1,620.00.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 54.2 |
| 50-day EMA | ₹1,571.60 — close is above |
| 200-day EMA | ₹1,393.72 — close is above |
| SuperTrend (10, 3) | ₹1,545.51 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
AUROPHARMA is a large-cap NSE stock in the Pharma sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹69,412 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 45.4% of AUROPHARMA's traded volume was marked for delivery (3,08,460 shares delivered). The 20-day average delivery is 51.1%.
AUROPHARMA closed at ₹1,623.00 on 26 Aug 2026 (+0.32% vs the previous close).
52-week high ₹1,682.40, 52-week low ₹1,016.10. The latest close is -3.53% from the 52-week high.